Fortress Biotech (FBIO) Shares Outstanding (2010 - 2026)
Fortress Biotech (FBIO) posted quarterly Shares Outstanding (Entity) of $31.4 million for Q4 2025, up 50.9% year-over-year from $20.8 million in Q4 2024, and up 1.16% quarter-over-quarter from $31.0 million in Q3 2025.
Analysis
Fortress Biotech (FBIO) Shares Outstanding (2010 - 2026) Analysis & Trends
Fortress Biotech's Shares Outstanding (Entity) history runs 16 years deep, the most recent figure standing at $31.4 million for Q4 2025.
- In Q4 2025, Shares Outstanding (Entity) rose 50.9% year-over-year to $31.4 million; the TTM figure through Dec 2025 stood at $31.4 million (up 50.9% YoY), while the FY2025 annual figure was $31.4 million, up 50.9% from the prior year.
- Shares Outstanding (Entity) for Q4 2025 stood at $31.4 million, up from $31.0 million in the prior quarter.
- The five-year high for Shares Outstanding (Entity) was $31.4 million in Q4 2025, with the low at $5.4 million in Q1 2021.
- The 5-year median for Shares Outstanding (Entity) is $8.4 million (2023), against an average of $13.9 million.
- The sharpest annual moves came in 2022 and 2024: Shares Outstanding (Entity) rose 6.68% in 2022, then soared 185.24% in 2024.
- Fortress Biotech's Shares Outstanding (Entity) stood at $5.4 million in 2021, then increased by 8.78% to $5.9 million in 2022, then surged by 36.89% to $8.1 million in 2023, then surged by 156.25% to $20.8 million in 2024, then jumped by 50.9% to $31.4 million in 2025.
- Business Quant data shows FBIO's Shares Outstanding (Entity) at $31.4 million in Q4 2025, $31.0 million in Q3 2025, and $29.8 million in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn | 61.30 Mn |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn | 398.00 Mn |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - | 210.89 Mn |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn | 111.58 Mn |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn | 133.61 Mn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 445.06 Mn |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | 217.35 Mn |
| 10 | Fortress Biotech | 86.15 Mn | -110.42 Mn | 12.58 Mn | 31.79 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 31.79 Mn |
| Dec 31, 2025 | 27.90 Mn |
| Sep 30, 2025 | 27.24 Mn |
| Jun 30, 2025 | 26.88 Mn |
| Mar 31, 2025 | 26.45 Mn |
| Dec 31, 2024 | 20.78 Mn |
| Sep 30, 2024 | 19.70 Mn |
| Jun 30, 2024 | 18.32 Mn |
| Mar 31, 2024 | 17.15 Mn |
| Dec 31, 2023 | 8.11 Mn |
| Sep 30, 2023 | 7.50 Mn |
| Jun 30, 2023 | 7.38 Mn |
| Mar 31, 2023 | 6.79 Mn |
| Dec 31, 2022 | 5.93 Mn |
| Sep 30, 2022 | 5.96 Mn |
| Jun 30, 2022 | 5.92 Mn |
| Mar 31, 2022 | 5.75 Mn |
| Dec 31, 2021 | 5.45 Mn |
| Sep 30, 2021 | 5.42 Mn |
| Jun 30, 2021 | 5.40 Mn |